CoChat
Sign Up
Cited by 24Cardiovascular and exercise physiologyBlood Pressure and Hypertension StudiesPhysical Activity and Health

Exercise systolic blood pressure at moderate workload predicts cardiovascular disease and mortality through 35 years of follow-up in healthy, middle-aged men

Open access
Mariampillai, Julian E., Engeseth, Kristian, Kjeldsen, Sverre E., Grundvold, Irene, Liestøl, Knut, Erikssen, Gunnar, Erikssen, Jan, Bodegard, Johan +1 more·2017·Blood Pressure
DOI 10.1080/08037051.2017.1291276
Open this paper in CoChat — free accountOpen PDF

Abstract

OBJECTIVE: There is an association between exercise systolic blood pressure (SBP) and cardiovascular disease and mortality. The aim of this study was to investigate this association, with 35 years of follow-up. METHODS: Through 1972-75, 2014 healthy, middle-aged men underwent thorough medical examination and a bicycle exercise test. 1999 participants completed six minutes at 100 W. SBP was measured manually, both before the test and every two minutes during the test. Highest SBP measured during the first six minutes (SBP100W) was used in further analyses. RESULTS: Participants were divided into quartiles (Q) based on their SBP100W; Q1: 100-160 mm Hg (n = 457), Q2: 165-175 mm Hg (n = 508), Q3: 180-195 mm Hg (n = 545) and Q4: 200-275 mm Hg (n = 489). After 35-years follow-up, there was a significant association between exercise SBP at baseline and cardiovascular disease and mortality. In the multivariate analysis adjusting for resting SBP, age, smoking status, total serum cholesterol and family history of coronary heart disease, as well as physical fitness, there is a 1.39-fold (CI: 1.00-1.93, p = 0.05) increased risk of cardiovascular mortality in Q4 compared to Q1. When not adjusting for physical fitness, there is a 1.29-fold (CI: 1.03-1.61, p = 0.02) increase in risk of cardiovascular disease between Q1 and Q4. CONCLUSIONS: The results of this study suggest that the association between exercise SBP at moderate workload and cardiovascular disease and mortality in middle-aged men extends through as long as 35 years and into old ages.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/08037051.2017.1291276

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent literature is mostly unanimous that exaggerated exercise blood pressure during submaximal exercise predicts future development of hypertension in general populations without high resting blood pressure.

    “Recent literature also is mostly unanimous with respect to the utility of EEBP during submaximal exercise to predict the future development of hypertension in general populations without high resting BP (6,58).”

    From Cardiorespiratory Fitness, Workload, and the Blood Pressure Response to Exercise Testing (2022) · cites this paper as [58]

    The General Discussion (page unavailable) says exaggerated exercise systolic blood pressure has been associated with future hypertension. It does not establish that the literature is mostly unanimous about prediction specifically during submaximal exercise in general populations without high resting blood pressure. The Clinical Relevance and Demographic Change section (page unavailable) also notes a lack of consensus on what constitutes an exaggerated exercise response. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

  • More recent longitudinal studies and a further meta-analysis have confirmed the CVD risk associated with EEBP during submaximal exercise.

    “More recent longitudinal studies and a further meta-analysis have confirmed the CVD risk associated with EEBP during submaximal exercise [25,26,27].”

    From The Identification and Management of High Blood Pressure Using Exercise Blood Pressure: Current Evidence and Practical Guidance (2022) · cites this paper as [26]

  • EEBP during moderate intensity exercise is associated with the development of hypertension in populations without high resting BP.

    “Indeed, EEBP during moderate intensity exercise is associated with the development of hypertension in populations without high resting BP [20,26].”

    From The Identification and Management of High Blood Pressure Using Exercise Blood Pressure: Current Evidence and Practical Guidance (2022) · cites this paper as [26]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 82

  1. Ambrosio G, Betocchi S, Pace L, Losi MA, Perrone-Filardi P, Soricelli A, et al. Prolonged impairment of regional contractile function after resolution of exercise- induced angina. Evidence of myocardial stunning in patients with coronary artery disease. Circulation. 1996;94:2455-64.
  2. Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med. 1998;339:173-81.
  3. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211-21.
  4. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204-22.
  5. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-7.
  6. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50:e344-e418.
  7. Weissberg PL. Atherogenesis: current understanding of the causes of atheroma. Heart. 2000;83:247-52.
  8. Laurent S, Boutouyrie P. The structural factor of hypertension: large and small artery alterations. Circ Res. 2015;116:1007-21.
  9. Boutouyrie P, Chowienczyk P, Humphrey JD, Mitchell GF. Arterial stiffness and cardiovascular risk in hypertension. Circ Res. 2021;128:864-86.
  10. Chirinos JA, Segers P, Hughes T, Townsend R. Large-artery stiffness in health and disease. J Am Coll Cardiol. 2019;74:1237-63.
  11. Tsao CW, Lyass A, Larson MG, Levy D, Hamburg NM, Vita JA, et al. Relation of central arterial stiffness to incident heart failure in the community. J Am Heart Assoc. 2015;4: e002189.
  12. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318-27.
  13. Aven T. The risk concept-historical and recent development trends. Reliab Eng Syst Saf. 2012;99:33-44.
  14. Conrad K. The onset of schizophrenia: an attempt to form an analysis of delusion. Thieme Verlag. 1958.
  15. Leinweber D. Nerds on Wall Street: math, machines and wired markets. John Wiley and Sons, Inc., Hoboken, New Jersey. 2009 pp. 137-140.
  16. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J. Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33-50.
  17. Rossello X, Dorresteijn JA, Janssen A, Lambrinou E, Scherrenberg M, Bonnefoy- Cudraz E, et al. Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). Eur J Cardiovasc Nurs. 2019;18:534-44.
  18. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987-1003.
  19. D'Agostino RB, Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743-53.
  20. Selmer R, Igland J, Ariansen I, Tverdal A, Njølstad I, Furu K, et al. NORRISK 2: A Norwegian risk model for acute cerebral stroke and myocardial infarction. Eur J Prev Cardiol. 2017;24:773-82.
  21. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1223-49.
  22. Cooney MT, Vartiainen E, Laatikainen T, De Bacquer D, McGorrian C, Dudina A, et al. Cardiovascular risk age: concepts and practicalities. Heart. 2012;98:941-6.
  23. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37:2315-81.
  24. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021-104.
  25. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-98.
  26. Muller M, Smulders YM, de Leeuw PW, Stehouwer CD. Treatment of hypertension in the oldest old: a critical role for frailty? Hypertension. 2014;63:433-41.
  27. Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT, Jr., et al. Potential US population impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018;137:109-18.
  28. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310:959-68.
  29. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press. 2018;27:314-40.
  30. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-13.
  31. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull. 1994;50:272-98.
  32. Whelton PK, Carey RM, Aronow WS, Casey DE, Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13-e115.
  33. Mariampillai JE, Eskås PA, Heimark S, Kjeldsen SE, Narkiewicz K, Mancia G. A case for less intensive blood pressure bontrol: it matters to achieve target blood pressure early and sustained below 140/90 mmHg. Prog Cardiovasc Dis. 2016;59:209-18.
  34. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43:1731-7.
  35. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998;316:1043-7.
  36. Njølstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation. 1996;93:450-6.
  37. Prescott E, Scharling H, Osler M, Schnohr P. Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study. J Epidemiol Community Health. 2002;56:702-6.
  38. Shah RS, Cole JW. Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther. 2010;8:917-32.
  39. Bhat VM, Cole JW, Sorkin JD, Wozniak MA, Malarcher AM, Giles WH, et al. Dose- response relationship between cigarette smoking and risk of ischemic stroke in young women. Stroke. 2008;39:2439-43.
  40. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med. 1985;313:1511-4.
  41. Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581-90.
  42. Wilt TJ, Bloomfield HE, MacDonald R, Nelson D, Rutks I, Ho M, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med. 2004;164:1427-36.
  43. Naci H, Brugts JJ, Fleurence R, Tsoi B, Toor H, Ades AE. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials. Eur J Prev Cardiol. 2013;20:641-57.
  44. Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, et al. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015;372:1500-9.
  45. Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, et al. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015;372:1489-99.
  46. Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376:1713-22.
  47. Yaghi S, Elkind MS. Lipids and cerebrovascular disease: research and practice. Stroke. 2015;46:3322-8.
  48. Sesso HD, Lee IM, Gaziano JM, Rexrode KM, Glynn RJ, Buring JE. Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation. 2001;104:393-8.
  49. Shea S, Ottman R, Gabrieli C, Stein Z, Nichols A. Family history as an independent risk factor for coronary artery disease. J Am Coll Cardiol. 1984;4:793-801.
  50. Lloyd-Jones DM, Nam BH, D'Agostino RB, Sr., Levy D, Murabito JM, Wang TJ, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle- aged adults: a prospective study of parents and offspring. JAMA. 2004;291:2204-11.
  51. Murabito JM, Pencina MJ, Nam BH, D'Agostino RB, Sr., Wang TJ, Lloyd-Jones D, et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle- aged adults. JAMA. 2005;294:3117-23.
  52. Zöller B, Li X, Sundquist J, Sundquist K. Multiplex sibling history of coronary heart disease is a strong risk factor for coronary heart disease. Eur Heart J. 2012;33:2849- 55.
  53. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994;330:1041-6.
  54. Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med. 2002;252:247-54.
  55. McPherson R, Tybjaerg-Hansen A. Genetics of coronary artery disease. Circ Res. 2016;118:564-78.
  56. Erdmann J, Kessler T, Munoz Venegas L, Schunkert H. A decade of genome-wide association studies for coronary artery disease: the challenges ahead. Cardiovasc Res. 2018;114:1241-57.
  57. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979;59:8-13.
  58. Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014;383:970-83.
  59. Erikssen J. Physical fitness and coronary heart disease morbidity and mortality. A prospective study in apparently healthy, middle aged men. Acta Med Scand Suppl. 1986;711:189-92.
  60. Erikssen G, Liestøl K, Bjørnholt J, Thaulow E, Sandvik L, Erikssen J. Changes in physical fitness and changes in mortality. Lancet. 1998;352:759-62.
  61. Prestgaard E, Mariampillai JE, Engeseth K, Erikssen J. Change in cardiorespiratory fitness and risk of stroke and death: long-term follow-up of healthy middle-aged men. Stroke. 2019;50:155-161
  62. Bonjer FH. Measurement of working capacity by assessment of the aerobic capacity in a single session. Fed Proc. 1966;25:1363-5.
  63. Prestgaard E, Mariampillai JE, Engeseth K, Erikssen J. Change in body weight and long-term risk of stroke and death in healthy men. Stroke. 2020;51:1435-41.
  64. Erikssen J, Dale J, Rootwelt K, Myhre E. False suspicion of coronary heart disease: a 7 year follow-up study of 36 apparently healthy middle-aged men. Circulation. 1983;68:490-7.
  65. Erikssen J, Myhre E. False positive exercise ECG: a misnomer? Int J Cardiol. 1984;6:263-8.
  66. Bodegard J, Erikssen G, Bjørnholt JV, Gjesdal K, Thelle D, Erikssen J. Symptom- limited exercise testing, ST depressions and long-term coronary heart disease mortality in apparently healthy middle-aged men. Eur J Cardiovasc Prev Rehabil. 2004;11:320- 7.
  67. Prestgaard E, Hodnesdal C, Engeseth K, Erikssen J, Bodegård J, Liestøl K, et al. Long-term predictors of stroke in healthy middle-aged men. Int J Stroke. 2018;13:292- 300.
  68. Carneiro HA, Song RJ, Lee J, Schwartz B, Vasan RS, Xanthakis V. Association of blood pressure and heart rate responses to submaximal exercise with incident heart failure: The Framingham Heart Study. J Am Heart Assoc. 2021;10:e019460.
  69. Kurl S, Laukkanen JA, Rauramaa R, Lakka TA, Sivenius J, Salonen JT. Systolic blood pressure response to exercise stress test and risk of stroke. Stroke. 2001;32:2036-41.
  70. Bouzas-Mosquera Mdel C, Bouzas-Mosquera A, Peteiro J, Broullón FJ, Alvarez- García N, Castro-Beiras A. Exaggerated exercise blood pressure response and risk of stroke in patients referred for stress testing. Eur J Intern Med. 2014;25:533-7.
  71. Irving JB, Bruce RA, DeRouen TA. Variations in and significance of systolic pressure during maximal exercise (treadmill) testing. Am J Cardiol. 1977;39:841-8.
  72. Naughton J, Dorn J, Oberman A, Gorman PA, Cleary P. Maximal exercise systolic pressure, exercise training, and mortality in myocardial infarction patients. Am J Cardiol. 2000;85:416-20.
  73. Dorn J, Naughton J, Imamura D, Trevisan M. Prognostic value of peak exercise systolic blood pressure on long-term survival after myocardial infarction. Am J Cardiol. 2001;87:213-6, a8.
  74. Gupta MP, Polena S, Coplan N, Panagopoulos G, Dhingra C, Myers J, et al. Prognostic significance of systolic blood pressure increases in men during exercise stress testing. Am J Cardiol. 2007;100:1609-13.
  75. Schultz MG, Hare JL, Marwick TH, Stowasser M, Sharman JE. Masked hypertension is "unmasked" by low-intensity exercise blood pressure. Blood Press. 2011;20:284-9.
  76. Schultz MG, La Gerche A, Sharman JE. Blood Pressure Response to Exercise and Cardiovascular Disease. Curr Hypertens Rep. 2017;19:89.
  77. Kayrak M, Bacaksiz A, Vatankulu MA, Ayhan SS, Kaya Z, Ari H, et al. Exaggerated blood pressure response to exercise-a new portent of masked hypertension. Clin Exp Hypertens. 2010;32:560-8.
  78. Keller K, Stelzer K, Ostad MA, Post F. Impact of exaggerated blood pressure response in normotensive individuals on future hypertension and prognosis: Systematic review according to PRISMA guideline. Adv Med Sci. 2017;62:317-29.
  79. Tanaka S, Masuda T, Kamada Y, Hamazaki N, Kamiya K, Ogura MN, et al. Excessive SBP elevation during moderate exercise discriminates patients at high risk of developing left ventricular hypertrophy from hypertensive patients. J Hypertens. 2018;36:1291-8.
  80. Laukkanen JA, Kurl S, Rauramaa R, Lakka TA, Venäläinen JM, Salonen JT. Systolic blood pressure response to exercise testing is related to the risk of acute myocardial infarction in middle-aged men. Eur J Cardiovasc Prev Rehabil. 2006;13:421-8.
  81. Thanassoulis G, Lyass A, Benjamin EJ, Larson MG, Vita JA, Levy D, et al. Relations of exercise blood pressure response to cardiovascular risk factors and vascular function in the Framingham Heart Study. Circulation. 2012;125:2836-43. 100. Kim D, Ha JW. Hypertensive response to exercise: mechanisms and clinical implication. Clin Hypertens. 2016;22:17. 101.
  82. Addendum For the evaluation committee only. 1) Reference no. 68. Bonjer FH. Measurement of working capacity by assessment of the aerobic capacity in a single session. Fed Proc. 1966;25(4):1363-5. 2) Accept letter, National Archives of Norway

Cited by

Sorted by citations

Related

Authors
Mariampillai, J. E., Engeseth, K., Kjeldsen, S. E., Grundvold, I., Liestøl, K., Erikssen, G., Erikssen, J., Bodegard, J., & Skretteberg, P. T.
Affiliations
  • University of Oslo (NO)
  • Oslo University Hospital (NO)
  • Department of Cardiology, Oslo University Hospital, Oslo, Norway;
Corresponding author
Mariampillai, Julian E.
ORCID
Venue
Blood Pressure
Publisher
Informa UK Limited
Published
2017-02-16
Volume
26
Issue
4
Pages
229-236
ISSN
  • 0803-7051 (ISSN-L)
  • 1651-1999
DOI
10.1080/08037051.2017.1291276
OpenAlex
W2588675309
Cited by
24
References
22
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 2 · 2018: 3
FWCI
3.24
Type
journal article
Language
en
Open access
Locations
  • Blood Pressure (publishedVersion)
  • PubMed (publishedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Physiology › Physical Activity and Health
Keywords
cardiovascular disease, cardiovascular mortality, middle-aged men, bicycle exercise test, long-term follow-up, physical fitness, hypertension, coronary artery disease
MeSH terms
Adult, Blood Pressure, Cardiovascular Diseases, Follow-Up Studies, Humans, Male, Middle Aged, Risk Factors, Systole, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review